Heterogeneous DNA Methylation Patterns in the GSTP1 Promoter Lead to Discordant Results between Assay Technologies and Impede Its Implementation as Epigenetic Biomarkers in Breast Cancer.

Alnaes, Grethe I Grenaker; Ronneberg, Jo Anders; Kristensen, Vessela N; Tost, Jörg

Alnaes, Grethe I Grenaker; Ronneberg, Jo Anders; Kristensen, Vessela N; Tost, Jörg.

Afiliación

Alnaes GI; Department of Cancer genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo 0310, Norway. Grethe.I.Grenaker.Alnas@rr-research.no.
Ronneberg JA; Department of Cancer genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo 0310, Norway. Jo.Anders.Ronneberg@gmail.com.
Kristensen VN; Department of Cancer genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo 0310, Norway. v.n.kristensen@medisin.uio.no.
Tost J; Institute of Clinical Medicine, University of Oslo, Oslo 0318, Norway. v.n.kristensen@medisin.uio.no.

Genes (Basel) ; 6(3): 878-900, 2015 Sep 17.

Article en En | MEDLINE | ID: mdl-26393654

Palabras clave

DNA methylation; GSTP1; MSP; MethyLight; biomarker; breast cancer; heterogeneity; mass spectrometry; method; pyrosequencing

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Screening_studies Idioma: En Revista: Genes (Basel) Año: 2015 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google